Language:English|中文
The Current Position:Home > News Center
News Center
ACC007, Innovative Anti-AIDS Drug, First Appearance at the National AIDS Conference
2018-09-27 Source:Jiangsu Aidea Pharmaceutical Co., Ltd.

From September 27th to 29th, the 5th national conference on AIDS was held at the Haigeng meeting center in Yunnan. This conference is the national AIDS academic event with the largest number of participants, the widest coverage, the maximum amount of professional forums, the highest academic level and the most significant influence. It gathers the most cutting-edge information on prevention and treatment of AIDS and related diseases at home and abroad, attracting over 3000 experts, scholars, clinicians and representatives from enterprises and institutions participated.

During the conference, Aidea set up a display for its innovative anti-AIDS drug ACC007 with the theme of “Third Generation of NNRTI, Effectively Suppressing Viruses and Improving Quality of Life”, which attracted widespread attention from participating experts and clinical medical workers.

On the afternoon of the 28th, Aidea held the Enterprise Satellite Conference. Dr.Xiaoning Christopher Sheng, the company's vice president, introduced the research background and preclinical research of ACC007. Professor Fujie Zhang, leader of the AIDS clinical expert working group of the Ministry of Health, from Infection Clinical and Research Center of Beijing Ditan Hospital Capital Medical University, introduced the clinical research progress of ACC007.

ACC007 and ACC008 were affirmed by experts and scholars and widely concerned by clinical medical workers since their first appearance at the national academic conference.

Jiangsu Aidea Pharmaceutical Co., Ltd
Tel:0514-87530666
Email:[email protected]
Address:No.2 Liuzhuang Road, Hanjiang District, Yangzhou
版權歸 ? "Jiangsu Aidea Pharmaceutical Co., Ltd所有 蘇ICP備14046468號 Powered by vancheer